Moyamoya disease presented as a case of hemiplegic migraine

Siddiqui, Mmr; Khan, Shakeb A.; Hoque, M. A.; Rahman, Kazi Mohibur; Mondol, Mba; Mohammad, Quazi Deen

doi:10.1136/bcr.02.2010.2764

Cited by 9 publications

(8 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…We identified 7 cases of symptomatic HM: 3 patients with SWS and 1 patient with Moyamoya disease, CREST syndrome, PAVM, and systemic lupus erythematosus (SLE; Table ) . Each of the diseases shows evidence of vascular dysfunction, including both systemic and CNS vascular disorders.…”

Section: Resultsmentioning

confidence: 99%

“…As we perform our literature review regarding symptomatic HM, we find that vascular‐related theory is more substantiated by cases. (See Tables and ) Diseases including SWS, CREST syndrome, PAVM, Moyamoya disease, and SLE are prevalent causes of HM. Although these patients had no characteristic age at onset, sex, headache side, headache duration, weakness side or weakness duration, and frequency, they all show vascular abnormalities to various degrees, including both central and systemic blood vessels.…”

Section: Discussionmentioning

confidence: 99%

“…The motor weakness is often accompanied by other forms of aura, such as impaired vision, speech, or sensation. Even though the exact cause of HM is still unknown, symptomatic HM as a clinical symptom has been demonstrated to be associated with multiple neurological diseases, such as Sturge–Weber Syndrome (SWS), pulmonary arteriovenous malformation (PAVM), and moyamoya disease . However, no relation has yet to be found between HM and NIID.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Interrelated Pathogenesis? Neuronal Intranuclear Inclusion Disease Combining With Hemiplegic Migraine

Wang

Nie

et al. 2019

Headache

View full text Add to dashboard Cite

Background.-Neuronal intranuclear inclusion disease (NIID) is considered a heterogeneous disease because of its highly variable clinical manifestations. To date, there are no reports of NIID patients presenting with hemiplegic migraine (HM)-like headache, or of HM and NIID co-occurring as comorbidity, and the connection between these 2 seemingly unrelated clinical conditions has yet to be established.Method.-We present a patient with NIID who was previously diagnosed with HM. To determine the pathogenesis of HM in this NIID patient, we systematically reviewed published NIID and HM cases and cataloged them based on their clinical manifestations.Result.-The clinical manifestations of NIID is highly various; however, there is no case reported to date that shows HMlike symptoms or cerebral edema. All documented symptomatic HM cases show vascular dysfunction to various degrees, but none of them has been shown to be correlated with NIID. Conclusion.-Our patient is the first documented case in which HM and NIID occur simultaneously. Vascular dysfunctions that cause cerebral hypoperfusion and glucose hypometabolism, two of the dominant causes of symptomatic HM, may be associated with the accumulation of eosinophilic hyaline inclusions that cause NIID. However, the existence of inclusions may also alter neuronal behavior and indirectly cause cerebral hypoperfusion and glucose hypometabolism. Further research andobservations are needed to examine the relationship between HM and NIID. Key words: hemiplegic migraine, sporadic hemiplegic migraine, neuronal intranuclear inclusion disease Abbreviations: CNS central nervous system, CSF cerebrospinal fluid, CT computed tomography, DWI diffusion-weighted imaging, EEG electroencephalography, FHM familial hemiplegic migraine, HM hemiplegic migraine, ICHD International Classification of Headache Disorders, MRA magnetic resonance angiography, MRI magnetic resonance imaging, NIID neuronal intranuclear inclusion disease, PET positron emission tomography, PWI perfusion-weighted imaging, SHM sporadic hemiplegic migraine, SWI susceptibility weighted imaging (Headache 2020;60:382-395) Headache

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Interrelated Pathogenesis? Neuronal Intranuclear Inclusion Disease Combining With Hemiplegic Migraine

Wang

Nie

et al. 2019

Headache

View full text Add to dashboard Cite

show abstract

“…The co-occurrence of headache and transient lateralized neurologic dysfunction was common, and 1 child was diagnosed with hemiplegic migraine, which has been previously reported in moyamoya. 36 Hemiplegic migraine is very rare in childhood; however, with a mean age of onset of familial hemiplegic migraine of 16 years in males and 21 years in females. Seol et al 37 found that 44 of 204 (22%) children diagnosed with moyamoya had significant headaches at presentation, with a mean duration of 21 months.…”

Section: Discussionmentioning

confidence: 98%

Factors Associated with the Presentation of Moyamoya in Childhood

Amlie‐Lefond

Ellenbogen

2015

Journal of Stroke and Cerebrovascular Diseases

View full text Add to dashboard Cite

“…Преходящая очаговая симптоматика у пациента в дебюте болезни была расценена как аура мигрени, однако большая частота приступов в начале заболевания именно для данной формы мигрени является достаточно редким симптомом [30]. У пациента с диагностированной мигренью практически нет поводов заподозрить дебют БММ, в том числе потому, что мигренозные приступы не характерны для этой врожденной сосудистой патологии [1,11,18,31,32]. Однако очаговая неврологическая симптоматика, сопровождающая эпизоды цефалгий, у мальчика К. могла стать поводом для дифференциальной диагностики с ТИА.…”

Section: рис 3 больной к церебральная ангиографияunclassified

Clinical manifestations of the onset and diagnostic problems in children with moyamoya disease

Lvova

Jevneronok

Шалькевич

et al. 2016

Z. nevrol. psikhiatr. im. S.S. Korsakova

View full text Add to dashboard Cite

Moyamoya disease in children is a rarely diagnosed entity. Frequent headache is the first symptom of the disease. Headache associated with moya-moya disease (HAMD) is a separated entity reported in the literature. Variants of onset, a spectrum of primary diagnoses and diagnosis verification rate of moyamoya disease in 7 children are presented. A clinical case of moya-moya disease in a 9-year boy, who was primarily diagnosed with migraine with aura, is reported. The results presented by the authors as well as literature data indicate the necessity of using magnetic-resonance angiography in children with headache attacks and focal neurologic symptoms to identify this progressive vascular pathology and timely recommend a surgical treatment.

show abstract

Moyamoya disease presented as a case of hemiplegic migraine

Cited by 9 publications

References 12 publications

Interrelated Pathogenesis? Neuronal Intranuclear Inclusion Disease Combining With Hemiplegic Migraine

Interrelated Pathogenesis? Neuronal Intranuclear Inclusion Disease Combining With Hemiplegic Migraine

Factors Associated with the Presentation of Moyamoya in Childhood

Clinical manifestations of the onset and diagnostic problems in children with moyamoya disease

Contact Info

Product

Resources

About